반응식
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]([CH2:12][CH2:13][N:14]1[CH2:19][CH2:18][O:17][CH2:16][CH2:15]1)[C:7](=[O:20])[N:6]=[CH:5]2.[CH:21]1([NH:24][C:25](=[O:42])[C:26]2[CH:31]=[CH:30][C:29]([CH3:32])=[C:28](B3OC(C)(C)C(C)(C)O3)[CH:27]=2)[CH2:23][CH2:22]1>>[CH:21]1([NH:24][C:25](=[O:42])[C:26]2[CH:31]=[CH:30][C:29]([CH3:32])=[C:28]([C:2]3[CH:3]=[C:4]4[C:9](=[CH:10][CH:11]=3)[N:8]([CH2:12][CH2:13][N:14]3[CH2:19][CH2:18][O:17][CH2:16][CH2:15]3)[C:7](=[O:20])[N:6]=[CH:5]4)[CH:27]=2)[CH2:22][CH2:23]1참가 물질
3
실험 절차
The title compound was prepared as pale yellow solid, using 6-Bromo-1-(2-morpholinoethyl)quinazolin-2(1H)-one and N-cyclopropyl-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, by a method analogous to that described in Example 3 above. MS m/e 433 (M+H)+.
출처 및 근거
- ORD 기록
- ord-b49b4dc0bd0245bf9dc16706a45f8e8f
- 출처 데이터셋
- uspto-grants-2011_05
- 특허 번호
- US07935709B2
연결된 노트
불러오는 중…